Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/67016
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-N-terminal-kinase activation and PTEN upregulation |
Autor: | Redondo-Muñoz, Javier CSIC ORCID ; Escobar-Díaz, Elisabeth CSIC; Hernández del Cerro, Mercedes CSIC; Pandiella, Atanasio CSIC ORCID CVN ; Terol, María José; García-Marco, José A.; García-Pardo, Angeles CSIC ORCID | Fecha de publicación: | 1-sep-2010 | Editor: | American Association for Cancer Research | Citación: | Clinical Cancer Research, 16 (17) : 4382-4391 (2010) | Resumen: | Purpose: Arsenic trioxide (ATO) induces B-cell chronic lymphocytic leukemia (B-CLL) cell apoptosis in vitro. We sought to study the mechanism involved in this effect and whether ATO is suitable for combination therapies with protein kinase inhibitors. Experimental Design: B-CLL cells were isolated from the peripheral blood of 28 patients. Cell viability studies with ATO alone or in combination with kinase inhibitors were done by flow cytometry, Western blotting, and immunofluorescence analyses. Results: After 48 hours, 3 μmol/L ATO induced apoptosis (average 75%) in all B-CLL samples studied and with minimal effect on normal peripheral blood lymphocytes. Apoptosis entailed Akt and NF-κB inactivation, XIAP downregulation, and PTEN upregulation, thus implying inhibition of the phosphoinositide 3-kinase (PI3K) survival pathway. Indeed, the combination of ATO and PI3K inhibitors increased the apoptotic effect of either agent alone. ATO also induced c-jun-NH2 terminal kinase (JNK) activation, and this was crucial and required for subsequent apoptotic events, as inhibiting JNK activity by either gene silencing or specific inhibitors prevented Akt and NF-κB inactivation, caspase activation, and mitochondrial damage. Moreover, JNK activation was the earliest response to ATO, preceding and determining reactive oxygen species production. Conclusions: We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death. ATO may therefore constitute an efficient treatment for B-CLL, particularly in combined therapies | Descripción: | 10 páginas, 5 figuras -- PAGS nros. 4382-4391 | Versión del editor: | http://dx.doi.org/10.1158/1078-0432.CCR-10-0072 | URI: | http://hdl.handle.net/10261/67016 | DOI: | 10.1158/1078-0432.CCR-10-0072 | ISSN: | 1078- 0432 | E-ISSN: | 1557-3265; Print ISSN: 1078- 0432 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
restringido.pdf | 21,67 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
49
checked on 24-abr-2024
WEB OF SCIENCETM
Citations
44
checked on 26-feb-2024
Page view(s)
370
checked on 24-abr-2024
Download(s)
149
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.